Together, our data unveil a connection between the Δ8-SIGIRR expression and hyperinflammatory phenotype at the cellular level of CF airways and provide the novel concept that control of the SIGIRR splice switch, as well as IL-37 activation, could be previously undetermined targets for CF anti-inflammatory therapeutics. The gene discussed is IL37; the disease is cystic fibrosis.